Heterogeneity of Gestational Diabetes and Risk for Adverse Pregnancy Outcome: A Cohort Study

被引:0
|
作者
Gong, Yixin [1 ]
Wang, Qunhua [2 ]
Chen, Suyu [2 ]
Liu, Yujie [2 ]
Li, Chenghua
Kang, Rong [1 ,3 ]
Wang, Jing [1 ]
Wei, Tian [1 ]
Wang, Qin [1 ]
Li, Xianming [1 ]
Luo, Sihui [1 ]
Weng, Jianping [1 ]
Zheng, Xueying [1 ]
Ding, Yu [1 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Endocrinol, Div Life Sci & Med, Hefei 230001, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Obstet & Gynecol, Hefei 230001, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Cardiol, Div Life Sci & Med, Hefei 230001, Peoples R China
关键词
gestational diabetes; heterogeneity; insulin resistance; pregnancy outcomes; GLUCOSE-TOLERANCE; FASTING HYPERGLYCEMIA; INSULIN-RESISTANCE; MELLITUS; PATHOGENESIS; WOMEN; LIVER;
D O I
10.1210/clinem/dgae754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Diabetes is increasingly recognized as a heterogeneous disease, with clinical characteristics and outcome risks varying across different phenotypes. Evidence on heterogeneity of gestational diabetes (GDM) is yet to be provided. Objective: To investigate the insulin physiology and pregnancy outcomes of GDM phenotypes characterized by fasting hyperglycemia or postload hyperglycemia. Methods: A total of 2050 women who underwent a 75-g oral glucose tolerance test were prospectively recruited and followed until delivery. Women were categorized into normoglycemia (NGT, n = 936), isolated impaired fasting glucose (gestational-IFG, n = 378), and isolated impaired postload glucose tolerance (gestational-IGT, n = 736) groups. Fasting blood samples at mid-pregnancy were collected to measure C-peptide and insulin concentrations. Homeostasis model assessment (HOMA) and quantitative insulin sensitivity check index (QUICKI) were used to evaluate insulin physiology. Maternal and neonatal outcomes were recorded. Results: Gestational-IFG had greater insulin resistance (HOMA-IR 3.11 vs 2.25, QUICKI-C-peptide 0.94 vs 1.03, both P < .01), and gestationalIGT had worse (3-cell function (C-peptide 2.00 vs 2.26 ng/mL, P < .05), when compared to one another. Gestational-IFG was more strongly associated with excessive gestational weight gain (risk ratio ERR] 1.62; 95% CI, 1.18-2.23) and large-for-gestational-age infants (RR 1.45; 95% CI, 1.03-2.03) than gestational-IGT. The risk for neonatal brain injury was increased in gestational-IGT (RR 2.03; 95% CI, 1.04-4.09), but not in gestational-IFG (P = .439). Gestational-IGT showed a stronger association with the risk of preterm birth compared to gestational-IFG (RR 1.80; 95% CI, 1.02-3.36). Conclusion: GDM exhibits distinct insulin physiology profiles. Pregnancy outcome varies between each phenotype. These findings provide evidence on risk stratification and diverse strategies for the treatment of GDM.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A Longitudinal Study of Plasma Acylcarnitine Profiles and the Risk of Gestational Diabetes in a Multiracial Pregnancy Cohort
    Lin, Yuan
    Wu, Jing
    Zhu, Yeyi
    Liang, Liming
    Hinkle, Stefanie
    Rawal, Shristi
    Weir, Natalie
    Tsai, Michael
    Zhang, Cuilin
    DIABETES, 2017, 66 : A22 - A22
  • [22] Chronic hypertension and adverse pregnancy outcome: a cohort study
    Panaitescu, A. M.
    Syngelaki, A.
    Prodan, N.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 50 (02) : 228 - 235
  • [23] Chronic Hypertension and Adverse Pregnancy Outcome: A Cohort Study
    Panaitescu, A. M.
    Syngelaki, A.
    Prodan, N.
    Akolekar, R.
    Nicolaides, K. H.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (01) : 7 - 8
  • [24] Maternal age and adverse pregnancy outcome: a cohort study
    Khalil, A.
    Syngelaki, A.
    Maiz, N.
    Zinevich, Y.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (06) : 634 - 643
  • [25] Prehypertension During Pregnancy as a Risk Factor for Adverse Perinatal Outcome: A Historical Cohort Study
    Gonzalez-Valencia, Diana P.
    Valero-Rubio, Soraya Y.
    Grillo-Ardila, Carlos F.
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 132S - 132S
  • [26] Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population-based cohort study
    Yu, Ya-Hui
    Platt, Robert W.
    Reynier, Pauline
    Yu, Oriana H. Y.
    Filion, Kristian B.
    DIABETES OBESITY & METABOLISM, 2025, 27 (02): : 976 - 986
  • [27] Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes
    Macri, F.
    Pitocco, D.
    Di Pasquo, E.
    Salvi, S.
    Rizzi, A.
    Di Leo, M.
    Tartaglione, L.
    Di Stasio, E.
    Lanzone, A.
    De Carolis, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (14) : 4403 - 4410
  • [28] INCIDENCE OF GESTATIONAL DIABETES AND PREGNANCY OUTCOME
    Manaj, Aferdita
    Bylykbashi, Edlira
    Muhametaj, Mirton
    Bylykbashi, Ilta
    Abedinaj, Anjeza
    INTERNATIONAL JOURNAL OF ECOSYSTEMS AND ECOLOGY SCIENCE-IJEES, 2016, 6 (01): : 107 - 112
  • [29] Obesity, gestational diabetes and pregnancy outcome
    Yogev, Yariv
    Visser, Gerard H. A.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2009, 14 (02): : 77 - 84
  • [30] Pregnancy outcome in undiagnosed gestational diabetes
    Dehdashtian, Masoud
    Aletayeb, Seyyed Mohammad Hassan
    Moarefian, Shirin
    Kajbaf, Tahereh Ziaei
    Taheri, Mehri
    Aminzadeh, Majid
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (03) : 428 - 431